Literature DB >> 31686118

Association between glucose variation and lower extremity amputation incidence in individuals with type 2 diabetes: a nationwide retrospective cohort study.

Chia-Ing Li1,2, Hui-Man Cheng3,4, Chiu-Shong Liu1,2,5, Chih-Hsueh Lin1,5, Wen-Yuan Lin1,5, Mu-Cyun Wang1,5, Shing-Yu Yang6, Tsai-Chung Li7,8, Cheng-Chieh Lin9,10,11.   

Abstract

AIMS/HYPOTHESIS: Elevated glucose level is one of the risk factors for lower extremity amputation (LEA), but whether glycaemic variability confers independent risks of LEA remains to be elucidated. This study aimed to investigate the association between visit-to-visit glycaemic variability and minor and major LEA risks during 8 years of follow-up in type 2 diabetic individuals aged 50 years and older.
METHODS: This retrospective cohort study included 27,574 ethnic Chinese type 2 diabetic individuals aged ≥50 years from the National Diabetes Care Management Program in Taiwan. Glycaemic variability measures were presented as the CVs of fasting plasma glucose (FPG-CV) and of HbA1c (A1c-CV). The effect of glycaemic variability on the incidence of LEA events was analysed using Cox proportional hazards models.
RESULTS: After a median follow-up of 8.9 years, 541 incident cases of LEA with a crude incidence density rate of 2.4 per 1000 person-years were observed. After multivariate adjustment, FPG-CV and A1c-CV were found to be significantly associated with minor LEA, with corresponding HRs of 1.53 (95% CI 1.15, 2.04) and 1.34 (95% CI 1.02, 1.77) for the third tertiles of FPG-CV and A1c-CV, respectively. In addition, these associations were stronger amongst older adults with longer diabetes duration (≥3 years) than amongst those with shorter duration (<3 years) (pinteraction < 0.01). CONCLUSIONS/
INTERPRETATION: Our study suggests that visit-to-visit variations in HbA1c and FPG are important predictors of minor LEA amongst older adults with type 2 diabetes, particularly for those with more than 3 years of diabetes duration.

Entities:  

Keywords:  Glycaemic variability; Lower extremity amputation; Type 2 diabetes

Mesh:

Substances:

Year:  2019        PMID: 31686118     DOI: 10.1007/s00125-019-05012-7

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  35 in total

1.  Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer.

Authors:  Kristy Pickwell; Volkert Siersma; Marleen Kars; Jan Apelqvist; Karel Bakker; Michael Edmonds; Per Holstein; Alexandra Jirkovská; Edward Jude; Didac Mauricio; Alberto Piaggesi; Gunnel Ragnarson Tennvall; Heinrich Reike; Maximilian Spraul; Luigi Uccioli; Vilma Urbancic; Kristien van Acker; Jeff van Baal; Nicolaas Schaper
Journal:  Diabetes Care       Date:  2015-02-09       Impact factor: 19.112

2.  Risk factors for foot infections in individuals with diabetes.

Authors:  Lawrence A Lavery; David G Armstrong; Robert P Wunderlich; M Jane Mohler; Christopher S Wendel; Benjamin A Lipsky
Journal:  Diabetes Care       Date:  2006-06       Impact factor: 19.112

3.  Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?

Authors:  Chin-Hsiao Tseng
Journal:  CMAJ       Date:  2006-01-31       Impact factor: 8.262

4.  A new diabetic foot risk assessment tool: DIAFORA.

Authors:  M Monteiro-Soares; M Dinis-Ribeiro
Journal:  Diabetes Metab Res Rev       Date:  2016-03-08       Impact factor: 4.876

5.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

6.  Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection.

Authors:  Benjamin A Lipsky; John A Weigelt; Xiaowu Sun; Richard S Johannes; Karen G Derby; Ying P Tabak
Journal:  Diabetes Care       Date:  2011-06-16       Impact factor: 19.112

7.  High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature.

Authors:  Wei Li; Ronald E Maloney; Tak Yee Aw
Journal:  Redox Biol       Date:  2015-04-02       Impact factor: 11.799

Review 8.  Systemic and renal oxidative stress in the pathogenesis of hypertension: modulation of long-term control of arterial blood pressure by resveratrol.

Authors:  Shereen M Hamza; Jason R B Dyck
Journal:  Front Physiol       Date:  2014-08-05       Impact factor: 4.566

9.  Development and validation of risk prediction equations to estimate future risk of blindness and lower limb amputation in patients with diabetes: cohort study.

Authors:  Julia Hippisley-Cox; Carol Coupland
Journal:  BMJ       Date:  2015-11-11

Review 10.  New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis.

Authors:  Ting Yuan; Ting Yang; Huan Chen; Danli Fu; Yangyang Hu; Jing Wang; Qing Yuan; Hong Yu; Wenfeng Xu; Xiang Xie
Journal:  Redox Biol       Date:  2018-10-19       Impact factor: 11.799

View more
  1 in total

1.  Self-Care in Type 2 Diabetes Patients with Urgency Lower Limb Amputation: The Influence of Sex, Marital Status and Previous Amputations.

Authors:  Simone Aparecida Domingos; Carolina Nunes França; Izabela Tuleta; Marianne Penachini da Costa Rezende Barbosa; Andre Luis Lacerda Bachi; Lucas Melo Neves
Journal:  Patient Prefer Adherence       Date:  2021-05-24       Impact factor: 2.711

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.